T
TRYP Therapeutics Inc
CNSX:TRYP
TRYP Therapeutics Inc
CNSX:TRYP
Price:
0.06
CAD
Market Cap:
CA$5.8m
Relative Value
There is not enough data to reliably calculate the relative value of TRYP.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRYP
Relative Value
Base Case
Not Available
Multiples Across Competitors
TRYP Competitors Multiples
TRYP Therapeutics Inc Competitors
TRYP Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
T
|
TRYP Therapeutics Inc
CNSX:TRYP
|
5.8m CAD | 0 | -1.2 | -0.9 | -0.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
957.3B USD | 14.7 | 46.3 | 31.3 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
589.5B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.4B CHF | 4.8 | 31 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.7B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
243.9B CHF | 5.5 | 22.3 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.1B USD | 4.6 | 16.5 | 10.3 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.4 | 19.5 | 7.3 | 9.7 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
